Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Frontiers in Pharmacology|November 30, 2016
Pharmacodynamic Modeling of Cell Cycle Effects for Gemcitabine and Trabectedin Combinations in Pancreatic Cancer CellsXin Miao, Gilbert Koch, Sihem Ait-Oudhia, et al.
Journal of Pharmaceutical Sciences|May 15, 2012
Physicochemical properties of epidermal growth factor receptor inhibitors and development of a nanoliposomal formulation of gefitinibBrian J Trummer, Vandana Iyer, Sathy V Balu-Iyer, et al.
Acta Biomaterialia|January 5, 2023
Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle depositionCara Moloney, Tista Roy Chaudhuri, Joseph A Spernyak, et al.
Clinical Immunology (Orlando, Fla.)|November 25, 2010
Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell functionPuneet Gaitonde, Aaron Peng, Robert M Straubinger, et al.
Molecular Cancer Therapeutics|August 1, 2019
Tumor Priming by SMO Inhibition Enhances Antibody Delivery and Efficacy in a Pancreatic Ductal Adenocarcinoma ModelJun Wang, Darren K W Chan, Arindam Sen, et al.
Journal of Pharmaceutical Sciences|September 29, 2011
Downregulation of CD40 signal and induction of TGF-β by phosphatidylinositol mediates reduction in immunogenicity against recombinant human Factor VIIIPuneet Gaitonde, Aaron Peng, Robert M Straubinger, et al.
The AAPS Journal|October 12, 2012
Interactions of everolimus and sorafenib in pancreatic cancer cellsDipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, et al.
Journal of Pharmaceutical Sciences|February 27, 2008
Passive transfer of polyethylene glycol to liposomal-recombinant human FVIII enhances its efficacy in a murine model for hemophilia AKarthik Ramani, Vivek Purohit, Razvan Miclea, et al.
Pageof 9